AMS - 2020-07FMid-Family Medicine - Infectious Diseases: HIV; STDs; Tuberculosis

$119.00$189.00

5 AMA PRA Category 1 Credits™
$119.00
$189.00
StreamingINCLUDED

Topics and Objectives

Title: FMid-Family Medicine – Infectious Diseases: HIV; STDs; Tuberculosis

Faculty: John Crane, M.D. Ph.D., Stephen J. Gluckman, M.D., F.A.C.P., F.I.D.S.A

Original Release Date: July 1, 2020  Expiration Date: July 1, 2023

TOPIC 1: What Every Primary Care Provider Should Know About HIV.

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Relate the present epidemiology of HIV.
  2. Develop an up-to-date understanding of the prognosis for a newly infected person.
  3. Assess the major viral and host factors that determine the present approach to the management of a person infected with HIV as per the NIH, CDC & IDSA Guidelines.
  4. Determine risk to health care workers and develop a plan to manage an exposed health care worker as per the current CDC and USPSTF Guidelines.

TOPIC 2: Sexually Transmitted Diseases.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Relate the present epidemiology of STDs in this country.
  2. Develop a differential diagnosis and a diagnostic and treatment approach for the following STD syndromes based on CDC guidelines:
    1. Urethritis;
    2. Vaginitis;
    3. Genital ulcer(s).
  3. Specify the diagnosis and management of syphilis, gonorrhea, chlamydia, herpes simplex, and HPV.
  4. Relate the proper use of a condom so that they may properly educate patients.

TOPIC 3:  Tuberculosis: Latent and Active

Primary care providers play a significant part in achieving the target of TB elimination because of their access to high-risk populations in their practices.  Using guidelines from the CDC, ATS and IDSA, an evidence-based approach on diagnosis and treatment will be reviewed.  Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Accurately explain to patients, family members, and other health care personnel the difference between active TB and latent TB
  2. Skillfully incorporate the use of interferon gamma release assays (IGRA’s) into testing for latent or active TB.
  3. Give an example of a special population for which a tuberculin skin test (TST) might still be used instead of an IGRA.
  4. Understand the changing epidemiology of non-TB mycobacteria in the U.S


Total Cost: $

Title: FMid-Family Medicine – Infectious Diseases: HIV; STDs; Tuberculosis

Faculty: John Crane, M.D. Ph.D., Stephen J. Gluckman, M.D., F.A.C.P., F.I.D.S.A

Original Release Date: July 1, 2020  Expiration Date: July 1, 2023

TOPIC 1: What Every Primary Care Provider Should Know About HIV.

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Relate the present epidemiology of HIV.
  2. Develop an up-to-date understanding of the prognosis for a newly infected person.
  3. Assess the major viral and host factors that determine the present approach to the management of a person infected with HIV as per the NIH, CDC & IDSA Guidelines.
  4. Determine risk to health care workers and develop a plan to manage an exposed health care worker as per the current CDC and USPSTF Guidelines.

TOPIC 2: Sexually Transmitted Diseases.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Relate the present epidemiology of STDs in this country.
  2. Develop a differential diagnosis and a diagnostic and treatment approach for the following STD syndromes based on CDC guidelines:
    1. Urethritis;
    2. Vaginitis;
    3. Genital ulcer(s).
  3. Specify the diagnosis and management of syphilis, gonorrhea, chlamydia, herpes simplex, and HPV.
  4. Relate the proper use of a condom so that they may properly educate patients.

TOPIC 3:  Tuberculosis: Latent and Active

Primary care providers play a significant part in achieving the target of TB elimination because of their access to high-risk populations in their practices.  Using guidelines from the CDC, ATS and IDSA, an evidence-based approach on diagnosis and treatment will be reviewed.  Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Accurately explain to patients, family members, and other health care personnel the difference between active TB and latent TB
  2. Skillfully incorporate the use of interferon gamma release assays (IGRA’s) into testing for latent or active TB.
  3. Give an example of a special population for which a tuberculin skin test (TST) might still be used instead of an IGRA.
  4. Understand the changing epidemiology of non-TB mycobacteria in the U.S